Bas Rutten transformed himself into one of the most recognizable figures in mixed martial arts through his competitive accomplishments and a successful transition to life after fighting.

Scholar Rock, a Boston-area biopharma company, announced the submission of a biologics license application and request of priority review for apitegromab to treat spinal muscular atrophy.

Goldberg, MD, MBA, discusses the role of multimodal imaging in geographic atrophy in the era of complement inhibitors. Imaging confirms the correct diagnosis, identifies which patients will be the ...

A 4-time WWE Champion has talked about his health issues and revealed that he has atrophy in both arms and is in constant pain. The star made the revelation in a recent interview. Kurt Angle was ...

Respected New Zealand Bloodstock agent Chris Rutten knows a thing or two about the hard yards. He will meticulously work his way through the catalogue and inspections at the Karaka sales this year - ...

Zacks Rank #3 (Hold) stock ARM Holdings (ARM) is a dominant player in the semiconductor industry due to its energy-efficient designs, which are critical to the function of smartphones, laptops ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...

You would think that Arm, which arguably has been the vanguard in the smartphone and PC industry push for improved power efficiency, would double down on that strategy in its plans for 2025.

Shares of Arm Holdings (NASDAQ: ARM) are soaring Wednesday. The stock is up 14.5% as of 11:50 a.m. ET, gaining as much as 17.8% earlier in the day. The leap comes as the S&P 500 and the Nasdaq ...

The headliner for this release is support for ARM64EC, the application binary interface (ABI) used for Arm apps in Windows 11, but the release notes say that the release contains "over 6,000 ...

Softbank, the majority owner of Arm, is participating in the new project, dubbed Stargate. Arm stock is expensive, but it offers clear competitive advantages. First, stocks jumped in Trump's first ...

For example, a 5/1 ARM will have the same rate for the first five years, then can adjust each year after that—meaning the rate might go up or down, based on the market. An ARM isn’t for everyone.